» Articles » PMID: 35279023

Incidence and Prevalence of Coronavirus Disease 2019 Within a Healthcare Worker Cohort During the First Year of the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

Abstract

Background: Preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2_ infections in healthcare workers (HCWs) is critical for healthcare delivery. We aimed to estimate and characterize the prevalence and incidence of coronavirus disease 2019 (COVID-19) in a US HCW cohort and to identify risk factors associated with infection.

Methods: We conducted a longitudinal cohort study of HCWs at 3 Bay Area medical centers using serial surveys and SARS-CoV-2 viral and orthogonal serological testing, including measurement of neutralizing antibodies. We estimated baseline prevalence and cumulative incidence of COVID-19. We performed multivariable Cox proportional hazards models to estimate associations of baseline factors with incident infections and evaluated the impact of time-varying exposures on time to COVID-19 using marginal structural models.

Results: A total of 2435 HCWs contributed 768 person-years of follow-up time. We identified 21 of 2435 individuals with prevalent infection, resulting in a baseline prevalence of 0.86% (95% confidence interval [CI], .53%-1.32%). We identified 70 of 2414 incident infections (2.9%), yielding a cumulative incidence rate of 9.11 cases per 100 person-years (95% CI, 7.11-11.52). Community contact with a known COVID-19 case was most strongly correlated with increased hazard for infection (hazard ratio, 8.1 [95% CI, 3.8-17.5]). High-risk work-related exposures (ie, breach in protective measures) drove an association between work exposure and infection (hazard ratio, 2.5 [95% CI, 1.3-4.8). More cases were identified in HCWs when community case rates were high.

Conclusions: We observed modest COVID-19 incidence despite consistent exposure at work. Community contact was strongly associated with infections, but contact at work was not unless accompanied by high-risk exposure.

Citing Articles

SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis.

Bansal A, Trieu M, Eriksson E, Zhou F, McVernon J, Brokstad K Sci Rep. 2025; 15(1):4705.

PMID: 39922967 PMC: 11807171. DOI: 10.1038/s41598-025-89472-5.


Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections.

Janke C, Rubio-Acero R, Weigert M, Reinkemeyer C, Khazaei Y, Kleinlein L Viruses. 2024; 16(10).

PMID: 39459890 PMC: 11512372. DOI: 10.3390/v16101556.


Investigating the Role of Serotonin Levels in Cognitive Impairments Associated with Long COVID-19.

Eslami Z, Joshaghani H Chonnam Med J. 2024; 60(3):141-146.

PMID: 39381125 PMC: 11458317. DOI: 10.4068/cmj.2024.60.3.141.


Incidence of SARS-CoV-2 infection among healthcare workers before and after COVID-19 vaccination in a tertiary paediatric hospital in Warsaw: A retrospective cohort study.

Kasztelewicz B, Skrok K, Burzynska J, Migdal M, Dzierzanowska-Fangrat K PLoS One. 2024; 19(5):e0301612.

PMID: 38781220 PMC: 11115228. DOI: 10.1371/journal.pone.0301612.


Assessment of the characteristics of COVID-19 infection among healthcare personnel working in long-term care facilities.

Mansoor A, ONeil C, McDonald D, Fraser V, Babcock H, Kwon J Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e81.

PMID: 38721487 PMC: 11077591. DOI: 10.1017/ash.2024.72.


References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Baker J, Nelson K, Overton E, Lopman B, Lash T, Photakis M . Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System. Ann Intern Med. 2021; 174(5):649-654. PMC: 7877798. DOI: 10.7326/M20-7145. View

3.
Gudbjartsson D, Norddahl G, Melsted P, Gunnarsdottir K, Holm H, Eythorsson E . Humoral Immune Response to SARS-CoV-2 in Iceland. N Engl J Med. 2020; 383(18):1724-1734. PMC: 7494247. DOI: 10.1056/NEJMoa2026116. View

4.
Fell A, Beaudoin A, DHeilly P, Mumm E, Cole C, Tourdot L . SARS-CoV-2 Exposure and Infection Among Health Care Personnel - Minnesota, March 6-July 11, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(43):1605-1610. PMC: 7641003. DOI: 10.15585/mmwr.mm6943a5. View

5.
Hernan M . A definition of causal effect for epidemiological research. J Epidemiol Community Health. 2004; 58(4):265-71. PMC: 1732737. DOI: 10.1136/jech.2002.006361. View